Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than Normal Blood Lipid Levels

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

November 30, 2014

Study Completion Date

November 30, 2014

Conditions
Hyperlipidemia
Interventions
DIETARY_SUPPLEMENT

Study Dietary Supplement (Prelipid 500 mg capsules)

Study Dietary Supplement (PreLipid 600 mg capsules) will be given to subjects twice daily 30 mins before food for 90 days along with lifestyle modification.

DIETARY_SUPPLEMENT

Placebo

Trial Locations (8)

122001

Division of Clinical & Preventive Cardiology, Heart Institute, Gurgaon

302017

Fortis Escorts Hospital, Jaipur

380014

Life Care Institute of Medical Science & Research, Ahmedabad

400007

Bhatia Hospital Medical Research Society, Mumbai

411005

Dr. Vikas Govind Pai Clinical Research Foundation, Pune

560043

Pace Clinical Research Center, Bangalore

600079

Singvi Health Centre, Chennai

606003

Rangammal Hospital, Tiruvannamalai

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Abbott

INDUSTRY

lead

PreEmptive Meds, Pvt. Ltd

INDUSTRY

NCT02187757 - Study to Evaluate Efficacy and Safety of PreLipid® on Subjects With Higher Than Normal Blood Lipid Levels | Biotech Hunter | Biotech Hunter